REMISSION-INDUCTION, CONSOLIDATION AND MAINTENANCE THERAPY BY AVA PROTOCOL IN ACUTE NONLYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
TORLONTANO, G
GERACI, L
LOMBARDO, M
DIMARZIO, A
IACONE, A
FIORITONI, G
BONANNI, G
DIBARTOLOMEO, P
BALLONE, E
DANTONIO, D
DIGIROLAMO, G
DARCANGELO, L
PANDOLI, G
NATALE, D
SPADANO, A
机构：
[1] UNIV CHIETI,CATTEDRA EMATOL,CHIETI,ITALY
[2] UNIV CHIETI,CATTEDRA IGIENE,CHIETI,ITALY
来源：
HAEMATOLOGICA | 1982年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：230 / 245
页数：16
相关论文
共 50 条
  • [21] SELECTIVE USE OF DAUNORUBICIN FOR REMISSION-INDUCTION CHEMOTHERAPY IN ACUTE NON-LYMPHOBLASTIC LEUKEMIA
    SHAIKH, BS
    DOUGHERTY, JB
    HAMILTON, RW
    BALLARD, JO
    PATEL, SB
    GEVIRTZ, NR
    EYSTER, ME
    CANCER, 1980, 46 (08) : 1731 - 1734
  • [22] ALTERATIONS IN ORAL MICROFLORA AND PATHOGENESIS OF ACUTE ORAL INFECTIONS DURING REMISSION-INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    BERGMANN, OJ
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (03) : 355 - 366
  • [23] INDUCTION THERAPY AND INTENSIVE CONSOLIDATION WITH DAUNORUBICIN, CYTOSINE-ARABINOSIDE, AND 6-THIOGUANINE IN ADULT ACUTE NONLYMPHOBLASTIC LEUKEMIA
    CASSILETH, PA
    KAHN, SB
    SILBER, R
    WEILER, C
    CANCER CLINICAL TRIALS, 1981, 4 (02) : 125 - 128
  • [24] VINDESINE (ELDISINE)-PREDNISONE IN REMISSION-INDUCTION OF LATE STAGE ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD
    VATS, TS
    SMITH, SD
    TRUEWORTHY, RC
    KLOPOVICH, P
    MEHTA, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 434 - 434
  • [25] INTENSIVE REMISSION CONSOLIDATION THERAPY IN THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA
    PREISLER, HD
    RAZA, A
    EARLY, A
    KIRSHNER, J
    BRECHER, M
    FREEMAN, A
    RUSTUM, Y
    AZARNIA, N
    PRIORE, R
    SANDBERG, A
    BLOCK, AM
    BROWMAN, G
    WALKER, I
    BENJER, A
    MILLER, K
    DARRIGO, P
    DOEBLIN, T
    STEIN, A
    BLOOM, M
    LOGUE, G
    RUSTAGI, P
    BARCOS, M
    LARSON, R
    JOYCE, R
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 722 - 730
  • [26] Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia
    E J Bow
    J B Meddings
    Leukemia, 2006, 20 : 2087 - 2092
  • [27] Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia
    Bow, E. J.
    Meddings, J. B.
    LEUKEMIA, 2006, 20 (12) : 2087 - 2092
  • [28] A phase II study of elacytarabine plus idarubicin as second course remission-induction therapy in patients with acute myeloid leukemia.
    Rizzieri, D.
    Krug, U.
    Schlenk, R. F.
    Vey, N.
    Thomas, X. G.
    Huguet, F.
    Johansen, M.
    Jacobsen, T. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] USE OF KARYOTYPIC ANALYSIS AS A PREDICTOR OF REMISSION-INDUCTION IN TREATMENT OF ACUTE MYELOID-LEUKEMIA IN THE ELDERLY
    WILLIAMS, GJ
    BOW, EJ
    SUTHERLAND, J
    RUBINGER, M
    SHORE, T
    SCHACTER, B
    BLOOD, 1994, 84 (10) : A628 - A628
  • [30] All trans retinoic acid in the remission induction and maintenance therapy for acute promyelocytic leukemia.
    Salim, KA
    Salim, A
    Sheika, A
    BLOOD, 1996, 88 (10) : 3434 - 3434
12345